Study of INCB123667 in Subjects With Advanced Solid Tumors
Incyte Corporation
Incyte Corporation
Zhejiang Doer Biologics Co., Ltd.
Pfizer
Turning Point Therapeutics, Inc.
Genentech, Inc.
Boston Scientific Corporation
Boston Scientific Corporation
Erasca, Inc.
Chinese University of Hong Kong
Fudan University
Eisai Inc.
Sichuan Baili Pharmaceutical Co., Ltd.
Institute of Oncology Ljubljana
Kumquat Biosciences Inc.
St. Jude Children's Research Hospital
Ukrainian Society of Clinical Oncology
Sichuan Baili Pharmaceutical Co., Ltd.
RenJi Hospital
Shanghai Juncell Therapeutics
Hospices Civils de Lyon
University Hospital, Lille
DualityBio Inc.
Elevation Oncology
Sun Yat-sen University
Sichuan Baili Pharmaceutical Co., Ltd.
Lund University Hospital
Shanghai Zhongshan Hospital
Pfizer
Fujian Cancer Hospital
Peking University
Ruijin Hospital
Hoffmann-La Roche
Sichuan Baili Pharmaceutical Co., Ltd.
Thomas Jefferson University
Thomas Jefferson University
Changchun GeneScience Pharmaceutical Co., Ltd.
Revolution Medicines, Inc.
National Cancer Center Hospital East
Medstar Health Research Institute
The First Hospital of Jilin University
Boston Scientific Corporation
Institut du Cancer de Montpellier - Val d'Aurelle
Zhejiang Cancer Hospital
Pfizer
Huashan Hospital
Sichuan Baili Pharmaceutical Co., Ltd.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University Hospital Heidelberg
Magentiq Eye LTD
Imunon